Therefore, after selectively binding to FOLR1 and being transported into cancer cells through receptor-mediated endocytosis, the linker unleashes its cytotoxic payload, eribulin, as a result of lysosomal protease cleavage. The gene discussed is FOLR1; the disease is cancer.